250 related articles for article (PubMed ID: 29293927)
1. Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923-2016.
O'Horo JC; Harper EP; El Rafei A; Ali R; DeSimone DC; Sakusic A; Abu Saleh OM; Marcelin JR; Tan EM; Rao AK; Sobel J; Tosh PK
Clin Infect Dis; 2017 Dec; 66(suppl_1):S43-S56. PubMed ID: 29293927
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Botulism and Use of Equine Botulinum Antitoxin in Children: A Systematic Review.
Griese SE; Kisselburgh HM; Bartenfeld MT; Thomas E; Rao AK; Sobel J; Dziuban EJ
Clin Infect Dis; 2017 Dec; 66(suppl_1):S17-S29. PubMed ID: 29293924
[TBL] [Abstract][Full Text] [Related]
3. Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup-Allergic Reactions to Botulinum Antitoxin: A Systematic Review.
Schussler E; Sobel J; Hsu J; Yu P; Meaney-Delman D; Grammer LC; Nowak-Wegrzyn A
Clin Infect Dis; 2017 Dec; 66(suppl_1):S65-S72. PubMed ID: 29293931
[TBL] [Abstract][Full Text] [Related]
4. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
Fan KL; Wang YL; Chu G; Leung LP
J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
[TBL] [Abstract][Full Text] [Related]
5. Botulism During Pregnancy and the Postpartum Period: A Systematic Review.
Badell ML; Rimawi BH; Rao AK; Jamieson DJ; Rasmussen S; Meaney-Delman D
Clin Infect Dis; 2017 Dec; 66(suppl_1):S30-S37. PubMed ID: 29293925
[TBL] [Abstract][Full Text] [Related]
6. [Botulism antitoxin treatment in two cases of foodborne botulism].
Tejada García M; Guindel Jiménez C
Farm Hosp; 2010; 34(1):47-8. PubMed ID: 20144823
[No Abstract] [Full Text] [Related]
7. [Foodbourne Botulism: A Forgotten Disease].
Neves P; Vicente J; Cabrera H; Pantazi I
Acta Med Port; 2018 Nov; 31(11):691-693. PubMed ID: 30521463
[TBL] [Abstract][Full Text] [Related]
8. Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.
Anderson DM; Kumar VR; Arper DL; Kruger E; Bilir SP; Richardson JS
PLoS One; 2019; 14(11):e0224700. PubMed ID: 31697731
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Early diagnosis and treatment in a child with foodborne botulism.
Proverbio MR; Lamba M; Rossi A; Siani P
Anaerobe; 2016 Jun; 39():189-92. PubMed ID: 26688278
[TBL] [Abstract][Full Text] [Related]
11. Foodborne botulism treated with heptavalent botulism antitoxin.
Hill SE; Iqbal R; Cadiz CL; Le J
Ann Pharmacother; 2013 Feb; 47(2):e12. PubMed ID: 23362041
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
[TBL] [Abstract][Full Text] [Related]
13. Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.
Gonul Oner O; Gudek HC; Erturk Cetin O; Demir S
Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):82-84. PubMed ID: 36728838
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT).
Bai L; Peng X; Liu Y; Sun Y; Wang X; Wang X; Lin G; Zhang P; Wan K; Qiu Z
Medicine (Baltimore); 2018 Aug; 97(34):e10659. PubMed ID: 30142749
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model.
Emanuel A; Qiu H; Barker D; Takla T; Gillum K; Neimuth N; Kodihalli S
PLoS One; 2019; 14(1):e0209019. PubMed ID: 30633746
[TBL] [Abstract][Full Text] [Related]
16. Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin.
Yu PA; Lin NH; Mahon BE; Sobel J; Yu Y; Mody RK; Gu W; Clements J; Kim HJ; Rao AK
Clin Infect Dis; 2017 Dec; 66(suppl_1):S57-S64. PubMed ID: 29293928
[TBL] [Abstract][Full Text] [Related]
17. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.
Tacket CO; Shandera WX; Mann JM; Hargrett NT; Blake PA
Am J Med; 1984 May; 76(5):794-8. PubMed ID: 6720725
[TBL] [Abstract][Full Text] [Related]
18. Retrospective survey to evaluate the safety and efficacy of Japanese botulinum antitoxin therapy in Japan.
Mottate K; Yokote H; Mori S; Horita A; Miyatsu Y; Torii Y; Kozaki S; Iwaki M; Takahashi M; Ginnaga A
Toxicon; 2016 Feb; 110():12-8. PubMed ID: 26615088
[TBL] [Abstract][Full Text] [Related]
19. Source of botulinum antitoxin products needs clarifying.
Fagan RP; Kim HJ
Pediatr Ann; 2010 May; 39(5):261-2. PubMed ID: 20521425
[No Abstract] [Full Text] [Related]
20. Early antitoxin treatment in wound botulism results in better outcome.
Chang GY; Ganguly G
Eur Neurol; 2003; 49(3):151-3. PubMed ID: 12646758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
